MedTrace Logo

Recovery Trajectories After Total Knee Arthroplasty

NCT07595861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-05-19

No results posted yet for this study

Summary

This prospective cohort study aimed to compare recovery trajectories following cruciate-retaining (CR) and posterior-stabilized (PS) total knee arthroplasty (TKA) using rehabilitation-centered patient-reported outcome measures (PROMs). Forty patients undergoing primary unilateral TKA were evaluated preoperatively and at 3 and 6 months postoperatively. Outcomes included pain intensity, functional status, kinesiophobia, health-related quality of life, and joint awareness assessed using validated PROMs including the Visual Analog Scale (VAS), WOMAC, Tampa Scale for Kinesiophobia (TSK), SF-36, and Forgotten Joint Score-12 (FJS-12). The study investigated whether posterior cruciate ligament management influences early postoperative recovery trajectories after TKA.

Conditions

  • Total Knee Anthroplasty
  • Patient Reported Outcome Measurements
  • Cruciate Ligament Reconstruction

Interventions

OTHER

Cruciate-Retaining Total Knee Arthroplasty

Primary unilateral total knee arthroplasty performed using a cruciate-retaining implant design in which the posterior cruciate ligament (PCL) was preserved. Implant selection was based on intraoperative assessment of ligament integrity and soft-tissue balance. Standardized perioperative management and postoperative rehabilitation protocols were applied to all participants.

OTHER

Posterior-Stabilized Total Knee Arthroplasty

Primary unilateral total knee arthroplasty performed using a posterior-stabilized implant design incorporating a post-cam mechanism to substitute posterior cruciate ligament (PCL) function. Implant selection was determined intraoperatively according to ligament condition and soft-tissue balancing requirements. All participants received standardized perioperative care and postoperative rehabilitation.

Sponsors & Collaborators

  • Ondokuz Mayıs University

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-07-01
Completion
2025-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07595861 on ClinicalTrials.gov